{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T22:04:48Z","timestamp":1781733888339,"version":"3.54.5"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"vor","delay-in-days":137,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R00 HL136658"],"award-info":[{"award-number":["R00 HL136658"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jbc.2021.100807","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T21:40:23Z","timestamp":1621460423000},"page":"100807","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Novel insulin sensitizer MSDC-0602K improves insulinemia and fatty liver disease in mice, alone and in combination with\u00a0liraglutide"],"prefix":"10.1016","volume":"296","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3096-8429","authenticated-orcid":false,"given":"Dakota R.","family":"Kamm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9478-3365","authenticated-orcid":false,"given":"Kelly D.","family":"Pyles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8740-7270","authenticated-orcid":false,"given":"Martin C.","family":"Sharpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5821-1853","authenticated-orcid":false,"given":"Laura N.","family":"Healy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3933-8626","authenticated-orcid":false,"given":"Jerry R.","family":"Colca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2381-1589","authenticated-orcid":false,"given":"Kyle S.","family":"McCommis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2021.100807_bib1","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.2337\/diabetes.54.suppl_2.S108","article-title":"Mechanisms of beta-cell death in type 2 diabetes","volume":"54 Suppl 2","author":"Donath","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.jbc.2021.100807_bib2","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.cell.2012.07.029","article-title":"Pancreatic beta cell dedifferentiation as a mechanism of diabetic beta cell failure","volume":"150","author":"Talchai","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2021.100807_bib3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.diabres.2006.08.015","article-title":"Beta-cell preservation with thiazolidinediones","volume":"76","author":"Campbell","year":"2007","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.jbc.2021.100807_bib4","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0006-2952(98)00052-5","article-title":"Comparative effects of englitazone and glyburide on gluconeogenesis and glycolysis in the isolated perfused rat liver","volume":"55","author":"Adams","year":"1998","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jbc.2021.100807_bib5","doi-asserted-by":"crossref","first-page":"PL89","DOI":"10.1016\/S0024-3205(97)01177-6","article-title":"Effect of troglitazone (Rezulin) on fructose 2,6-bisphosphate concentration and glucose metabolism in isolated rat hepatocytes","volume":"62","author":"Raman","year":"1998","journal-title":"Life Sci."},{"key":"10.1016\/j.jbc.2021.100807_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0014-2999(00)00806-2","article-title":"Role of glucose and insulin in thiazolidinedione-induced alterations in hepatic gluconeogenesis","volume":"409","author":"Raman","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jbc.2021.100807_bib7","doi-asserted-by":"crossref","first-page":"23537","DOI":"10.1074\/jbc.M112.363960","article-title":"Insulin resistance and metabolic derangements in obese mice are ameliorated by a novel peroxisome proliferator-activated receptor gamma-sparing thiazolidinedione","volume":"287","author":"Chen","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2021.100807_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061551","article-title":"Identification of a mitochondrial target of thiazolidinedione insulin sensitizers (mTOT)--relationship to newly identified mitochondrial pyruvate carrier proteins","volume":"8","author":"Colca","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2021.100807_bib9","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1073\/pnas.1303360110","article-title":"Thiazolidinediones are acute, specific inhibitors of the mitochondrial pyruvate carrier","volume":"110","author":"Divakaruni","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2021.100807_bib10","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.cmet.2015.07.028","article-title":"Loss of mitochondrial pyruvate carrier 2 in the liver leads to defects in gluconeogenesis and compensation via pyruvate-alanine cycling","volume":"22","author":"McCommis","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.jbc.2021.100807_bib11","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/clpt.2013.10","article-title":"Clinical proof-of-concept study with MSDC-0160, a prototype mTOT-modulating insulin sensitizer","volume":"93","author":"Colca","year":"2013","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jbc.2021.100807_bib12","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/jbmr.2364","article-title":"An insulin-sensitizing thiazolidinedione, which minimally activates\u00a0PPARgamma, does not cause bone loss","volume":"30","author":"Fukunaga","year":"2015","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.jbc.2021.100807_bib13","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jhep.2019.10.023","article-title":"Insulin sensitizer MSDC-0602K in non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled phase IIb study","volume":"72","author":"Harrison","year":"2020","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jbc.2021.100807_bib14","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.2337\/dc06-2593","article-title":"Liraglutide, a long-acting human glucagon-like peptide-1 analog, given as monotherapy significantly improves glycemic control and lowers body weight without risk of hypoglycemia in patients with type 2 diabetes","volume":"30","author":"Vilsboll","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jbc.2021.100807_bib15","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1172\/JCI75276","article-title":"The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss","volume":"124","author":"Secher","year":"2014","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jbc.2021.100807_bib16","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/hep.29025","article-title":"Targeting the mitochondrial pyruvate carrier attenuates fibrosis in a mouse model of nonalcoholic steatohepatitis","volume":"65","author":"McCommis","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jbc.2021.100807_bib17","doi-asserted-by":"crossref","first-page":"E163","DOI":"10.1152\/ajpendo.00023.2018","article-title":"Pioglitazone improves hepatic mitochondrial function in a mouse model of nonalcoholic steatohepatitis","volume":"315","author":"Kalavalapalli","year":"2018","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.jbc.2021.100807_bib18","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/jamainternmed.2016.9607","article-title":"Thiazolidinediones and advanced liver fibrosis in nonalcoholic steatohepatitis: A meta-analysis","volume":"177","author":"Musso","year":"2017","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.jbc.2021.100807_bib19","first-page":"1008","article-title":"Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone","volume":"38","author":"Neuschwander-Tetri","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jbc.2021.100807_bib20","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jbc.2021.100807_bib21","doi-asserted-by":"crossref","first-page":"305","DOI":"10.7326\/M15-1774","article-title":"Long-term pioglitazone treatment for patients with nonalcoholic steatohepatitis and prediabetes or type 2 diabetes mellitus: A randomized trial","volume":"165","author":"Cusi","year":"2016","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jbc.2021.100807_bib22","doi-asserted-by":"crossref","first-page":"G508","DOI":"10.1152\/ajpgi.00139.2019","article-title":"Liraglutide improves hepatic steatosis and metabolic dysfunctions in a 3-week dietary mouse model of nonalcoholic steatohepatitis","volume":"317","author":"Duparc","year":"2019","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.jbc.2021.100807_bib23","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/hepr.12351","article-title":"Pilot study of liraglutide effects\u00a0in non-alcoholic steatohepatitis and non-alcoholic fatty liver disease with glucose intolerance in Japanese patients (LEAN-J)","volume":"45","author":"Eguchi","year":"2015","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.jbc.2021.100807_bib24","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","article-title":"A\u00a0placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis","volume":"384","author":"Newsome","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jbc.2021.100807_bib25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.trsl.2020.07.008","article-title":"The GLP-1R agonist liraglutide limits hepatic lipotoxicity and inflammatory response in mice fed a methionine-choline deficient diet","volume":"227","author":"Somm","year":"2021","journal-title":"Transl. Res."},{"key":"10.1016\/j.jbc.2021.100807_bib26","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.molmet.2016.06.016","article-title":"An ancestral role for the mitochondrial pyruvate carrier in glucose-stimulated insulin secretion","volume":"5","author":"McCommis","year":"2016","journal-title":"Mol. Metab."},{"key":"10.1016\/j.jbc.2021.100807_bib27","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1463-1326.2008.00865.x","article-title":"Combination of the insulin sensitizer, pioglitazone, and the long-acting GLP-1 human analog, liraglutide, exerts potent synergistic glucose-lowering efficacy in severely diabetic ZDF rats","volume":"10","author":"Larsen","year":"2008","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.jbc.2021.100807_bib28","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.mce.2014.11.018","article-title":"Protective effects of pioglitazone and\/or liraglutide on pancreatic beta-cells in db\/db mice: Comparison of their effects between in an early and advanced stage of diabetes","volume":"400","author":"Kimura","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jbc.2021.100807_bib29","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2337\/diacare.25.3.517","article-title":"Dose-response effect of pioglitazone on insulin sensitivity and insulin secretion in type 2 diabetes","volume":"25","author":"Miyazaki","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jbc.2021.100807_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126642","article-title":"Pioglitazone increases whole body insulin sensitivity in obese, insulin-resistant rhesus monkeys","volume":"10","author":"Tozzo","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2021.100807_bib31","doi-asserted-by":"crossref","first-page":"E116","DOI":"10.1152\/ajpendo.00331.2003","article-title":"Pioglitazone preserves pancreatic islet structure and insulin secretory function in three murine models of type 2 diabetes","volume":"286","author":"Diani","year":"2004","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.jbc.2021.100807_bib32","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s13300-018-0401-9","article-title":"Pioglitazone improved insulin sensitivity and first phase insulin secretion among obese and lean people with diabetes: A multicenter clamp study","volume":"9","author":"Qian","year":"2018","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.jbc.2021.100807_bib33","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.2337\/diabetes.53.11.2844","article-title":"Pioglitazone reduces islet triglyceride content and restores impaired glucose-stimulated insulin secretion in heterozygous peroxisome proliferator-activated receptor-gamma-deficient mice on a high-fat diet","volume":"53","author":"Matsui","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.jbc.2021.100807_bib34","doi-asserted-by":"crossref","first-page":"13335","DOI":"10.1074\/jbc.M113.521666","article-title":"Mitochondrial metabolism of pyruvate is essential for regulating glucose-stimulated insulin secretion","volume":"289","author":"Patterson","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2021.100807_bib35","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1210\/en.2008-1557","article-title":"Pioglitazone acutely reduces insulin secretion and causes metabolic deceleration of the pancreatic beta-cell at submaximal glucose concentrations","volume":"150","author":"Lamontagne","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.jbc.2021.100807_bib36","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.2337\/db12-0428","article-title":"Pioglitazone acutely reduces energy metabolism and insulin secretion in rats","volume":"62","author":"Lamontagne","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.jbc.2021.100807_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062012","article-title":"Novel insulin sensitizer modulates nutrient sensing pathways and maintains beta-cell phenotype in human islets","volume":"8","author":"Rohatgi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2021.100807_bib38","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1007\/s00125-020-05275-5","article-title":"Augmented mitochondrial energy metabolism is an early response to chronic glucose stress in human pancreatic beta cells","volume":"63","author":"Chareyron","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.jbc.2021.100807_bib39","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1530\/JOE-16-0478","article-title":"The effects of liraglutide in mice with diet-induced obesity studied by metabolomics","volume":"233","author":"Buganova","year":"2017","journal-title":"J.\u00a0Endocrinol."},{"key":"10.1016\/j.jbc.2021.100807_bib40","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.cmet.2016.01.009","article-title":"Liraglutide compromises pancreatic beta cell function in a humanized mouse model","volume":"23","author":"Abdulreda","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.jbc.2021.100807_bib41","series-title":"Guide for the Care and Use of Laboratory Animals","year":"2011"},{"key":"10.1016\/j.jbc.2021.100807_bib42","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/j.celrep.2014.05.017","article-title":"Mitochondrial pyruvate carrier 2 hypomorphism in mice leads to defects in glucose-stimulated insulin secretion","volume":"7","author":"Vigueira","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.jbc.2021.100807_bib43","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1128\/MCB.21.8.2683-2694.2001","article-title":"Insulin control of glycogen metabolism in knockout mice lacking the muscle-specific protein phosphatase PP1G\/RGL","volume":"21","author":"Suzuki","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.jbc.2021.100807_bib44","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions","volume":"94","author":"Brunt","year":"1999","journal-title":"Am. J. Gastroenterol."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925821006025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925821006025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:29:40Z","timestamp":1762187380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925821006025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":44,"alternative-id":["S0021925821006025"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2021.100807","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.12.10.420190","asserted-by":"object"}]},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel insulin sensitizer MSDC-0602K improves insulinemia and fatty liver disease in mice, alone and in combination with\u00a0liraglutide","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2021.100807","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"100807"}}